Tasleem Raza
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Tasleem Raza has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Merlin Thomas
Pulmonary Division, Department of Chest, Hamad General Hospital, Doha, Qatar
4 shared publications - Wanis H. Ibrahim
Department of Pulmonology and Internal Medicine, Weill-Cornell Medicine & Hamad General Hospital, Doha, Qatar
4 shared publications - Ezzeddin A. Ibrahim
Department of Medical Oncology/Hematology, National Centre for Cancer Care and Research (NCCCR), Hamad Medical Corporation (HMC), Doha, Qatar
2 shared publications - Hisham Abdul Sattar
Pulmonary Division, Department of Medicine, Hamad Medical Corporation, Doha, Qatar
2 shared publications - Kamran Mushtaq
Hamad Medical Corporation, Doha, Qatar
2 shared publications - Mansoor Hameed
Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar
2 shared publications
Latest Publications
- Open Access
- 15 September 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (37) , e35107
A cross-sectional study from Qatar on the effect of influenza vaccination on the severity of COVID-19
To assess and compare the severity of corona virus disease 2019 (COVID-19) infection in patients with and without a history of influenza vaccination. In this cross-sectional study descriptive statistics were used to analyze COVID-19-related parameters, including demographics, comorbidities, and severity. Normally distributed data with mean, standard deviation, and 95% confidence interval (CI) were reported, while non-normally distributed data was presented with median and inter-quartile range. Categorical data was summarized using frequencies and percentages. Associations were assessed using Pearson Chi-square, Fisher Exact, t test, or Mann–Whitney U test. Univariate and multivariate logistic regression methods were used to evaluate the relationship between disease severity, clinical outcomes, influenza vaccination status, and other predictors. Significance was considered for p values < 0.05. Statistical analyses were done using SPSS V.27.0 (IBM Corp) and Epi Info (CDC) software. Between March 2020 and December 2020 before the availability of COVID-19 vaccination, 148,215 severe acute respiratory syndrome corona virus 2 positive patients were studied, with 3519 vaccinated against influenza, and 144,696 unvaccinated. After random sampling at 1:2 ratio, the final analysis included 3234 vaccinated and 5640 unvaccinated patients. The majority (95.4%) had mild or asymptomatic COVID-19, while 4.6% had severe or critical cases as defined by World Health Organization severity grading. Multivariate logistic regression analysis revealed that the vaccinated group had significantly less severe (adjusted odds ratio [OR] 0.683; 95% CI 0.513–0.911, P = .009) and critical (adjusted OR 0.345; 95% CI 0.145–0.822, P = .016) COVID-19 and were less likely to require oxygen therapy (adjusted OR 0.696; 95% CI 0.531–0.912, P = .009) after adjusting for confounders like age, gender and comorbidities. No significant differences in Intensive care unit admissions (adjusted OR 0.686; 95% CI 0.425–1.11, P = .122), mechanical ventilation (adjusted OR 0.631; 95% CI 0.308–1.295, P = .209) and mortality (adjusted OR 1.105; 95% CI 0.348–3.503, P = .866) were noted between the 2 groups. Influenza vaccination may significantly reduce the severity of COVID-19 but has no significant effect on intensive care unit admissions, mechanical ventilation and all- cause mortality.
- 15 September 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (37) , e35107
Open AccessA cross-sectional study from Qatar on the effect of influenza vaccination on the severity of COVID-19
To assess and compare the severity of corona virus disease 2019 (COVID-19) infection in patients with and without a history of influenza vaccination. In this cross-sectional study descriptive statistics were used to analyze COVID-19-related parameters, including demographics, comorbidities, and severity. Normally distributed data with mean, standard deviation, and 95% confidence interval (CI) were reported, while non-normally distributed data was presented with median and inter-quartile range. Categorical data was summarized using frequencies and percentages. Associations were assessed using Pearson Chi-square, Fisher Exact, t test, or Mann–Whitney U test. Univariate and multivariate logistic regression methods were used to evaluate the relationship between disease severity, clinical outcomes, influenza vaccination status, and other predictors. Significance was considered for p values < 0.05. Statistical analyses were done using SPSS V.27.0 (IBM Corp) and Epi Info (CDC) software. Between March 2020 and December 2020 before the availability of COVID-19 vaccination, 148,215 severe acute respiratory syndrome corona virus 2 positive patients were studied, with 3519 vaccinated against influenza, and 144,696 unvaccinated. After random sampling at 1:2 ratio, the final analysis included 3234 vaccinated and 5640 unvaccinated patients. The majority (95.4%) had mild or asymptomatic COVID-19, while 4.6% had severe or critical cases as defined by World Health Organization severity grading. Multivariate logistic regression analysis revealed that the vaccinated group had significantly less severe (adjusted odds ratio [OR] 0.683; 95% CI 0.513–0.911, P = .009) and critical (adjusted OR 0.345; 95% CI 0.145–0.822, P = .016) COVID-19 and were less likely to require oxygen therapy (adjusted OR 0.696; 95% CI 0.531–0.912, P = .009) after adjusting for confounders like age, gender and comorbidities. No significant differences in Intensive care unit admissions (adjusted OR 0.686; 95% CI 0.425–1.11, P = .122), mechanical ventilation (adjusted OR 0.631; 95% CI 0.308–1.295, P = .209) and mortality (adjusted OR 1.105; 95% CI 0.348–3.503, P = .866) were noted between the 2 groups. Influenza vaccination may significantly reduce the severity of COVID-19 but has no significant effect on intensive care unit admissions, mechanical ventilation and all- cause mortality.
- Open Access
- 28 November 2022
- Published by Springer Nature in Cureus
- Vol. 14 (11) , e31991
Clinical Outcomes of COVID-19-Induced Acute Respiratory Distress Syndrome in Patients With Three Different Respiratory Support Modalities: A Retrospective Cohort Study
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced acute respiratory failure and acute respiratory distress syndrome (ARDS) had a considerable impact on intensive care utilization and resource optimization. Multiple modalities for respiratory support were implemented during the COVID-19 pandemic with the main concern of being able to identify those patients at high risk of rapidly progressive respiratory failure, whom the early initiation of invasive respiratory support would, in particular, affect the outcome in comparison to the noninvasive management strategy. In our cohort study, we describe demographic characteristics, respiratory support modalities, and their relation to patient outcomes. Patients 18 years of age and older who were admitted to a tertiary center COVID-19-dedicated medical intensive care unit (MICU) in Qatar between March 2020 and May 2020 with a confirmed diagnosis of COVID-19 pneumonia were included in this study. Patients were divided into invasive or noninvasive, and those who required invasive strategy were subdivided into the early intubation group (patients who were intubated within 72 hours of intensive care unit (ICU) admission) and the late intubation group (patients who were intubated after 72 hours from ICU admission). The primary outcome was ICU and hospital mortality, and the secondary effects were the length of stay and mortality determinants. A total of 686 patients were admitted to the medical intensive care unit (MICU) during the study period. There were 222 (32.4%), 131 (19.1%), and 333 (48.5%) patients in the early, late, and not intubated groups, respectively. Compared to the late intubated group, the early intubated group had a higher proportion of males. Diabetes (39.8%) was the most common comorbidity, followed by hypertension (HTN) (36%) and heart disease (9.8%). The 30-day ICU and hospital mortality were significantly higher in the late intubated group compared to the early intubated group (30.5% versus 15.8%, and 30% versus 16.2%). The median ICU and hospital stay days in the total sample were 8 (interquartile range (IQR): 5-14) and 19 (IQR: 14-25), respectively. The mean estimates of 30-day ICU survival times for early intubated, late intubated, and not intubated groups were 25.14 (95% confidence interval (CI): 23.71, 26.57), 23.35 (95% CI: 21.63, 25.07), and 29.91 (95% CI: 29.74, 30.09) respectively. In our study, the COVID-19 ARDS patients who required early invasive ventilatory support and in whom the physiological parameter was more severe (Acute Physiology and Chronic Health Evaluation II (APACHE II) and Sequential Organ Failure Assessment (SOFA) scores) had a better outcome than the late intubation group. Age more than 60 years old, diabetes, hypertension, chronic kidney disease (CKD), and chronic liver disease (CLD) were the main predictor of mortality in total.
- 28 November 2022
- Published by Springer Nature in Cureus
- Vol. 14 (11) , e31991
Open AccessClinical Outcomes of COVID-19-Induced Acute Respiratory Distress Syndrome in Patients With Three Different Respiratory Support Modalities: A Retrospective Cohort Study
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced acute respiratory failure and acute respiratory distress syndrome (ARDS) had a considerable impact on intensive care utilization and resource optimization. Multiple modalities for respiratory support were implemented during the COVID-19 pandemic with the main concern of being able to identify those patients at high risk of rapidly progressive respiratory failure, whom the early initiation of invasive respiratory support would, in particular, affect the outcome in comparison to the noninvasive management strategy. In our cohort study, we describe demographic characteristics, respiratory support modalities, and their relation to patient outcomes. Patients 18 years of age and older who were admitted to a tertiary center COVID-19-dedicated medical intensive care unit (MICU) in Qatar between March 2020 and May 2020 with a confirmed diagnosis of COVID-19 pneumonia were included in this study. Patients were divided into invasive or noninvasive, and those who required invasive strategy were subdivided into the early intubation group (patients who were intubated within 72 hours of intensive care unit (ICU) admission) and the late intubation group (patients who were intubated after 72 hours from ICU admission). The primary outcome was ICU and hospital mortality, and the secondary effects were the length of stay and mortality determinants. A total of 686 patients were admitted to the medical intensive care unit (MICU) during the study period. There were 222 (32.4%), 131 (19.1%), and 333 (48.5%) patients in the early, late, and not intubated groups, respectively. Compared to the late intubated group, the early intubated group had a higher proportion of males. Diabetes (39.8%) was the most common comorbidity, followed by hypertension (HTN) (36%) and heart disease (9.8%). The 30-day ICU and hospital mortality were significantly higher in the late intubated group compared to the early intubated group (30.5% versus 15.8%, and 30% versus 16.2%). The median ICU and hospital stay days in the total sample were 8 (interquartile range (IQR): 5-14) and 19 (IQR: 14-25), respectively. The mean estimates of 30-day ICU survival times for early intubated, late intubated, and not intubated groups were 25.14 (95% confidence interval (CI): 23.71, 26.57), 23.35 (95% CI: 21.63, 25.07), and 29.91 (95% CI: 29.74, 30.09) respectively. In our study, the COVID-19 ARDS patients who required early invasive ventilatory support and in whom the physiological parameter was more severe (Acute Physiology and Chronic Health Evaluation II (APACHE II) and Sequential Organ Failure Assessment (SOFA) scores) had a better outcome than the late intubation group. Age more than 60 years old, diabetes, hypertension, chronic kidney disease (CKD), and chronic liver disease (CLD) were the main predictor of mortality in total.
- Open Access
Dynamic Ventilatory circuit divider: Safer way to multiply the number of available ventilators
Background: Recent pandemic has brought a sudden surge in the requirement of mechanical ventilators all over the world. In this backdrop, there is wide interest in looking for ways to support multiple patients from a single ventilator. Various solutions, based upon simple mechanical division of the ventilator tubings are described. However, recently warnings have been issued by multiple international professional societies against these plumbing solutions as it can seriously harm the patients. Methods: We have bifurcated the inspiratory and expiratory conduits from a single ventilator with addition of one way valves, pressure and flow sensors along with volume and PEEP control. A purpose-built software and a low-cost microcontroller based control system integrates and displays the data in the familiar ventilatory graphic and numerical format onto a generic screen. The system is calibrated with simulated lungs with varying compliance. In addition to the standard microbial, heat and moisture exchanger filters we design to add UV-C lights at 254-260 nanometre wavelength in the expiratory channel for its virucidal effect. Results: The dynamic ventilatory divider system is capable of providing and controlling individual flow, tidal volume (TV) and Positive End-expiratory pressure (PEEP) for individual patients. Furthermore, it would also display the ventilatory parameters of both the patients, on a single split screen, in a familiar format. FiO2 and rate are still controlled by the mother ventilator. Conclusions: The prototype system has a potential to provide safe ventilation to at least two individuals from a single ventilator, while maintaining the unique requirements of each patient.
Open AccessDynamic Ventilatory circuit divider: Safer way to multiply the number of available ventilators
Background: Recent pandemic has brought a sudden surge in the requirement of mechanical ventilators all over the world. In this backdrop, there is wide interest in looking for ways to support multiple patients from a single ventilator. Various solutions, based upon simple mechanical division of the ventilator tubings are described. However, recently warnings have been issued by multiple international professional societies against these plumbing solutions as it can seriously harm the patients. Methods: We have bifurcated the inspiratory and expiratory conduits from a single ventilator with addition of one way valves, pressure and flow sensors along with volume and PEEP control. A purpose-built software and a low-cost microcontroller based control system integrates and displays the data in the familiar ventilatory graphic and numerical format onto a generic screen. The system is calibrated with simulated lungs with varying compliance. In addition to the standard microbial, heat and moisture exchanger filters we design to add UV-C lights at 254-260 nanometre wavelength in the expiratory channel for its virucidal effect. Results: The dynamic ventilatory divider system is capable of providing and controlling individual flow, tidal volume (TV) and Positive End-expiratory pressure (PEEP) for individual patients. Furthermore, it would also display the ventilatory parameters of both the patients, on a single split screen, in a familiar format. FiO2 and rate are still controlled by the mother ventilator. Conclusions: The prototype system has a potential to provide safe ventilation to at least two individuals from a single ventilator, while maintaining the unique requirements of each patient.
- Open Access
- 1 May 2019
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 82, 96-101
Diagnostic value of bronchoalveolar lavage in the subset of patients with negative sputum/smear and mycobacterial culture and a suspicion of pulmonary tuberculosis
- 1 May 2019
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 82, 96-101
Open AccessDiagnostic value of bronchoalveolar lavage in the subset of patients with negative sputum/smear and mycobacterial culture and a suspicion of pulmonary tuberculosis
- Open Access
- 1 December 2017
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 65, 75-80
Effects of procalcitonin-guided treatment on antibiotic use and need for mechanical ventilation in patients with acute asthma exacerbation: Meta-analysis of randomized controlled trials
- 1 December 2017
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 65, 75-80
Open AccessEffects of procalcitonin-guided treatment on antibiotic use and need for mechanical ventilation in patients with acute asthma exacerbation: Meta-analysis of randomized controlled trials
- Open Access
- 22 November 2017
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 17 (1) , 151
Medical thoracoscopy for exudative pleural effusion: an eight-year experience from a country with a young population
With the exception of areas with high prevalence of tuberculosis, medical thoracoscopy is becoming the diagnostic modality of choice for exudative pleural effusions. The aims of this study were to determine the diagnostic yield and safety of medical thoracoscopy for exudative pleural effusions and ascertain the etiology of such effusions in Qatar. This is a retrospective-descriptive study of 407 patients who underwent diagnostic medical thoracoscopy for exudative pleural effusions from January, 2008 till December, 2015 at the only tertiary referral center performing this procedure in Qatar. Tuberculosis was the most common etiology of exudative pleural effusions in Qatar accounting for 84.5% of all causes. Around 85% of patients were young males (mean age of 33 ± 12.1 years). The diagnostic yield of medical thoracoscopy for tuberculous pleural effusion was 91.4%. Malignant pleural effusions accounted for 5.2% of cases. Minor bleeding occurred in 1.2% of cases with no procedure-related mortality observed. Medical thoracoscopy is a very safe procedure. Tuberculous pleuritis is by far the most common etiology of exudative pleural effusions in Qatar. Closed needle biopsy is a worth consideration as an initial safe, easy and low-cost diagnostic modality for exudative pleural effusions in this country.
- 22 November 2017
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 17 (1) , 151
Open AccessMedical thoracoscopy for exudative pleural effusion: an eight-year experience from a country with a young population
With the exception of areas with high prevalence of tuberculosis, medical thoracoscopy is becoming the diagnostic modality of choice for exudative pleural effusions. The aims of this study were to determine the diagnostic yield and safety of medical thoracoscopy for exudative pleural effusions and ascertain the etiology of such effusions in Qatar. This is a retrospective-descriptive study of 407 patients who underwent diagnostic medical thoracoscopy for exudative pleural effusions from January, 2008 till December, 2015 at the only tertiary referral center performing this procedure in Qatar. Tuberculosis was the most common etiology of exudative pleural effusions in Qatar accounting for 84.5% of all causes. Around 85% of patients were young males (mean age of 33 ± 12.1 years). The diagnostic yield of medical thoracoscopy for tuberculous pleural effusion was 91.4%. Malignant pleural effusions accounted for 5.2% of cases. Minor bleeding occurred in 1.2% of cases with no procedure-related mortality observed. Medical thoracoscopy is a very safe procedure. Tuberculous pleuritis is by far the most common etiology of exudative pleural effusions in Qatar. Closed needle biopsy is a worth consideration as an initial safe, easy and low-cost diagnostic modality for exudative pleural effusions in this country.
- Open Access
- 14 February 2017
- Published by Hamad bin Khalifa University Press (HBKU Press) in Qatar Medical Journal
- Vol. 2017 (1)
300 plus days on ECMO – lessons learned
Background: Veno-venous extracorporeal membrane oxygenation (VV-ECMO) provides the respiratory support in acute severe respiratory failure until the underlying acute lung pathology improves. 1,2 VV-ECMO support for >100 days is rare and in most situations requires a destination therapy of lung transplant. 3,4 This may not be an option in some centers. We had our longest ECMO case of >300 days with severe residual fibrotic lung disease and inability to wean off ECMO. This presentation briefly discusses the multifaceted challenges and lessons learned from this experience. Discussion/lessons learned: Prolonged ECMO can lead to various challenges, some of which are briefly described below. 1. General ECMO-related issues: These are more common due to prolonged ECMO run and include membrane failure, thrombosis, DIC, etc. Right ventricular failure may prove to be a terminal event in these patients. 2. Rare ECMO-related issues: Prolonged heparin therapy may lead to osteoporosis and heparin-induced thrombocytopenia (HIT). Our patient had positive HIT and was managed with prolonged argatroban therapy. 3. Unusual complications: Extensive fibrocavitary lung disease can lead to large lung cavities impairing gas exchange. Percutaneous pleuropulmonary procedures are at high risk during ECMO. We performed percutaneous drainage of a large bullous lesion without any untoward event. Unexpected hypoglycemia and type II lactic acidosis were also unusual events in our patient. Potential etiologies and management of these rare events will be discussed during the presentation. 4. Team morale and psychosocial support: Prolonged ECMO patient care with no destination therapy can be extremely stressful for care givers. Frequent debriefing sessions may help to mitigate these issues. Formal personal psychological support should be readily available to all team members to mitigate stress-related complications. 5. Skin integrity and musculoskeletal function: Besides the adequate nutrition, mobility and muscle exercises are extremely important to maintain musculoskeletal functional status. We were actively mobilizing our patient while on ECMO to prevent these complications. 6. Psychosocial issues for the patient: Prolonged ECMO, ICU stay, limited mobility, and limited family connections are a rich recipe for depression and other psychosocial issues. Team members from patient's country, birthday and other celebrations, involvement of embassy staff, and use of social media to communicate with the family back home may help to mitigate some of these issues. 7. Ethical and other considerations: ECMO to “nowhere” creates tension among the team members due to different views about the ongoing care of these patients. 5 Consideration of withdrawal of care is a major ethical issue and needs to be resolved by involvement of all team members, local ethics committee, religious scholars' input, consideration of local policies, and input from the patient and any available family members. 8. ECMO to “nowhere” to “somewhere”: Exploration for non-regional transplant centers and resolution of financial constraints by support from the local embassy, social services support, hospital administration, charitable organization, and conducting fund-raising activities. Conclusion: Prolonged ECMO therapy poses its unique challenges. Good team dynamics, frequent debriefing sessions, and ethic consultations are extremely important during care of these patients. Innovative solutions and collaboration with regional and distant transplant centers may provide an opportunity for destination therapy in these patients.
- 14 February 2017
- Published by Hamad bin Khalifa University Press (HBKU Press) in Qatar Medical Journal
- Vol. 2017 (1)
Open Access300 plus days on ECMO – lessons learned
Background: Veno-venous extracorporeal membrane oxygenation (VV-ECMO) provides the respiratory support in acute severe respiratory failure until the underlying acute lung pathology improves. 1,2 VV-ECMO support for >100 days is rare and in most situations requires a destination therapy of lung transplant. 3,4 This may not be an option in some centers. We had our longest ECMO case of >300 days with severe residual fibrotic lung disease and inability to wean off ECMO. This presentation briefly discusses the multifaceted challenges and lessons learned from this experience. Discussion/lessons learned: Prolonged ECMO can lead to various challenges, some of which are briefly described below. 1. General ECMO-related issues: These are more common due to prolonged ECMO run and include membrane failure, thrombosis, DIC, etc. Right ventricular failure may prove to be a terminal event in these patients. 2. Rare ECMO-related issues: Prolonged heparin therapy may lead to osteoporosis and heparin-induced thrombocytopenia (HIT). Our patient had positive HIT and was managed with prolonged argatroban therapy. 3. Unusual complications: Extensive fibrocavitary lung disease can lead to large lung cavities impairing gas exchange. Percutaneous pleuropulmonary procedures are at high risk during ECMO. We performed percutaneous drainage of a large bullous lesion without any untoward event. Unexpected hypoglycemia and type II lactic acidosis were also unusual events in our patient. Potential etiologies and management of these rare events will be discussed during the presentation. 4. Team morale and psychosocial support: Prolonged ECMO patient care with no destination therapy can be extremely stressful for care givers. Frequent debriefing sessions may help to mitigate these issues. Formal personal psychological support should be readily available to all team members to mitigate stress-related complications. 5. Skin integrity and musculoskeletal function: Besides the adequate nutrition, mobility and muscle exercises are extremely important to maintain musculoskeletal functional status. We were actively mobilizing our patient while on ECMO to prevent these complications. 6. Psychosocial issues for the patient: Prolonged ECMO, ICU stay, limited mobility, and limited family connections are a rich recipe for depression and other psychosocial issues. Team members from patient's country, birthday and other celebrations, involvement of embassy staff, and use of social media to communicate with the family back home may help to mitigate some of these issues. 7. Ethical and other considerations: ECMO to “nowhere” creates tension among the team members due to different views about the ongoing care of these patients. 5 Consideration of withdrawal of care is a major ethical issue and needs to be resolved by involvement of all team members, local ethics committee, religious scholars' input, consideration of local policies, and input from the patient and any available family members. 8. ECMO to “nowhere” to “somewhere”: Exploration for non-regional transplant centers and resolution of financial constraints by support from the local embassy, social services support, hospital administration, charitable organization, and conducting fund-raising activities. Conclusion: Prolonged ECMO therapy poses its unique challenges. Good team dynamics, frequent debriefing sessions, and ethic consultations are extremely important during care of these patients. Innovative solutions and collaboration with regional and distant transplant centers may provide an opportunity for destination therapy in these patients.
- Open Access
- 31 October 2016
- Published by Springer Nature in BMC Neurology
- Vol. 16 (1) , 1-4
Somatic survival and organ donation among brain-dead patients in the state of Qatar
The Qatari law, as in many other countries, uses brain death as the main criteria for organ donation and cessation of medical support. By contrast, most of the public in Qatar do not agree with the limitation or withdrawal of medical care until the time of cardiac death. The current study aims to examine the duration of somatic survival after brain death, organ donation rate in brain-dead patients as well as review the underlying etiologies and level of support provided in the state of Qatar. This is a retrospective study of all patients diagnosed with brain death over a 10-year period conducted at the largest tertiary center in Qatar (Hamad General Hospital). Among the 53 patients who were diagnosed with brain death during the study period, the median and mean somatic survivals of brain-dead patients in the current study were 3 and 4.5 days respectively. The most common etiology was intracranial hemorrhage (45.3%) followed by ischemic stroke (17%). Ischemic stroke patients had a median survival of 11 days. Organ donation was accepted by only two families (6.6%) of the 30 brain dead patients deemed suitable for organ donation. The average somatic survival of brain-dead patients is less than one week irrespective of supportive measures provided. Organ donation rate was extremely low among brain-dead patients in Qatar. Improved public education may lead to significant improvement in resource utilization as well as organ transplant donors and should be a major target area of future health care policies.
- 31 October 2016
- Published by Springer Nature in BMC Neurology
- Vol. 16 (1) , 1-4
Open AccessSomatic survival and organ donation among brain-dead patients in the state of Qatar
The Qatari law, as in many other countries, uses brain death as the main criteria for organ donation and cessation of medical support. By contrast, most of the public in Qatar do not agree with the limitation or withdrawal of medical care until the time of cardiac death. The current study aims to examine the duration of somatic survival after brain death, organ donation rate in brain-dead patients as well as review the underlying etiologies and level of support provided in the state of Qatar. This is a retrospective study of all patients diagnosed with brain death over a 10-year period conducted at the largest tertiary center in Qatar (Hamad General Hospital). Among the 53 patients who were diagnosed with brain death during the study period, the median and mean somatic survivals of brain-dead patients in the current study were 3 and 4.5 days respectively. The most common etiology was intracranial hemorrhage (45.3%) followed by ischemic stroke (17%). Ischemic stroke patients had a median survival of 11 days. Organ donation was accepted by only two families (6.6%) of the 30 brain dead patients deemed suitable for organ donation. The average somatic survival of brain-dead patients is less than one week irrespective of supportive measures provided. Organ donation rate was extremely low among brain-dead patients in Qatar. Improved public education may lead to significant improvement in resource utilization as well as organ transplant donors and should be a major target area of future health care policies.